
Zuprinor 10 Transdermal Patch

Save more with additional offers



Save more with additional offers




General Information






Product introduction
Your doctor will explain how to use Zuprinor 10 Transdermal Patch. Follow the instructions carefully to get the most benefit. The dose and duration will depend on what you are using it for and how well it helps your symptoms. Use it regularly and do not discontinue using it until the doctor tells you it is alright to stop.
The most common side effects of this medicine include constipation, dizziness, drowsiness, headache, and nausea. You may have side effects more often when you start your treatment or when your dose is increased. Usually, the side effects will slowly go away as your body gets used to it. If they are severe or do not go away, you should remove your patch and contact your doctor.
Before using the medicine, you should tell your doctor if you have any other illnesses or disorders. It may also affect, or be affected by some other drugs you are using. Let your doctor know all the other medicines you are taking or using to make sure it is safe for you. Pregnant and breastfeeding women should consult their doctors first before using the medicine.
Uses of Zuprinor Transdermal Patch
- Opioid (Morphine) dependence
Benefits of Zuprinor Transdermal Patch
Zuprinor 10 Transdermal Patch reduces cravings and withdrawal symptoms, making it easier for individuals to stop using opioids. As a partial opioid agonist, it helps stabilize brain function without producing the intense "high" associated with opioid misuse, which lowers the risk of relapse. Zuprinor 10 Transdermal Patch also supports long-term recovery by reducing the need for more harmful opioids and can be combined with counseling or behavioral therapies for a comprehensive approach to overcoming addiction.
Side effects of Zuprinor Transdermal Patch
- Headache
- Drowsiness
- Insomnia (difficulty in sleeping)
- Dizziness
- Vomiting
- Weakness
- Sweating
- Nausea
- Back pain
- Abdominal pain
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
How to use Zuprinor Transdermal Patch
How Zuprinor Transdermal Patch works
Quick tips
- Zuprinor 10 Transdermal Patch should be used as advised by the doctor.
- You should change the patch every 7 days and apply a new patch to a new site.
- Do not expose the patches to a heat source.
- Avoid drinking alcohol or taking other medicines that can cause drowsiness.
- It has a high potential for abuse, misuse, or addiction even at normal doses.
- Discontinue the medicine and inform your doctor if you experience difficulty breathing.
- Do not stop taking Zuprinor 10 Transdermal Patch without talking to your doctor first as it may cause a worsening of symptoms.
- Take it at the same time every day to help you remember to take it.
- To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
- Use caution while driving or doing anything that requires concentration as Zuprinor 10 Transdermal Patch can cause dizziness and sleepiness.
- Avoid drinking alcohol or taking other medicines that can cause drowsiness.
- Discontinue the medicine and inform your doctor if you experience difficulty breathing.
- Do not stop taking Zuprinor 10 Transdermal Patch without talking to your doctor first as it may cause a worsening of symptoms.
- Your doctor may get regular blood tests to check for liver function while taking this medicine.
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
Consider the use of an alternate analgesic that may permit more flexibility with the dosing in patients with severe hepatic impairment.
Interaction with drugs
Naltrexone (Oral Route)
Alprazolam (Oral Route)
Alprazolam (Injection Route)
Chlordiazepoxide (Oral Route)
Clobazam (Oral Route)
Frequently asked questions
Fact Box
Chemical Class
Habit Forming
Therapeutic Class
Action Class
Related lab tests
References
- Schumacher MA, Basbaum AI, Way WL. Opioids Analgesics & Antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 546-47.
- Yaksh TL, WallaceIn MS. Opioids, Analgesia, and Pain Management. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 510.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 165-67.
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 02 Apr. 2019] (online) Available from:




Want to know more
We provide you with authentic, trustworthy and relevant informationHave issue with the content
Disclaimer
Marketer details
Address: Plot no 107/108,Namli block , Ranipool, East Sikkim 737135 || Khasra No. 1335-1340,Near EPIP- I, Vill - Bhatoli Kalan ,Baddi, Solan, Himachal Pradesh, 173205
Vendor Details
Lab tests offered by us
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)














